Dx PCR Home Platform
22/02/2023 14:42
Feb 22 (Reuters) - Co-Diagnostics Inc CODX.O :
* CO-DIAGNOSTICS, INC. INITIATES CLINICAL EVALUATIONS FOR
ITS
AT-HOME AND POINT-OF-CARE CO-DX PCR HOME™ PLATFORM
Source text for Eikon: ID:nPnbBzsg0a
Further company coverage: CODX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Co-Diagnostics
See all newsDiagnostics' Joint Venture Cosara Diagnostics Announces Publication Of Peer-Reviewed Hpv Screening Study Using Cosara's Saragene® Test
Diagnostics - Cosara To Initiate Sales Activities Across India And South Asia
Diagnostics’ Brian Brown Stepped Down As CFO Effective September 2
Diagnostics Q2 revenue rises slightly amid international expansion
Diagnostics - Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale - SEC Filing